ey0017.14-12 | (1) | ESPEYB17
I Mahu
, A Barateiro
, E Rial-Pensado
, N Martinez-Sanchez
, SH Vaz
, PMSD Cal
, B Jenkins
, T Rodrigues
, C Cordeiro
, MF Costa
, R Mendes
, E Seixas
, MMA Pereira
, N Kubasova
, V Gres
, I Morris
, C Temporao
, M Olivares
, Y Sanz
, A Koulman
, F Corzana
, AM Sebastiao
, M Lopez
, GJL Bernardes
, AI Domingos
To read the full abstract: Cell Metab. 2020 Jun 2;31(6):1120-1135.e7. doi: 10.1016/j.cmet.2020.04.013.This experimental rodent study of a PEGylated amphetamine (PEGyAMPH) designed to not cross the blood brain barrier is interesting for 2 reasons. First, it shows that its peripheral anti-obesity effects alone (without the central anorexic effects of amphetamine) are sufficient to achieve...